Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-20

Clinical Trial Update: Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluated a combination of zoledronic acid and teriparatide in women with osteoporosis. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)
  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-04-20